Reduced HBV Seroprotection
Adult HBV Vaccination: Identifying Individuals at Risk for Reduced Seroprotection

Released: May 05, 2022

Expiration: May 04, 2023

Robert G. Gish
Robert G. Gish, MD

Activity

Progress
1
Course Completed
In this episode, learn about the importance of identifying adults at risk for reduced hepatitis B virus (HBV) seroprotection and applying current HBV vaccine recommendations in special populations. Listen as Robert G. Gish, MD, discusses key information on the identification and evaluation of patients who have chronic health conditions and therefore may be at risk for nonresponse to available vaccines.